CervoMed (CRVO) Shares Issued (2012 - 2026)
CervoMed (CRVO) posted Shares Issued of $1.3 million for Q1 2026, up 29.53% sequentially from $992701.0 in Q4 2025, and up 234.94% YoY from $383895.0 in Q1 2025.
CervoMed (CRVO) Shares Issued (2012 - 2026) Analysis & Trends
CervoMed has reported Shares Issued for 15 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Shares Issued rose 234.94% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 234.94% YoY) and the FY2025 annual result came in at $992701.0, up 55.89% from the prior year.
- Shares Issued grew to $1.3 million in Q1 2026 per CRVO's latest filing, from $992701.0 in the prior quarter.
- Over five years, Shares Issued peaked at $1.3 million in Q1 2026 and troughed at $49039.0 in Q1 2022.
- A 5-year average of $449238.6 and a median of $349374.0 in 2022 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2024: Shares Issued sank 92.31% in 2022, then surged 520.4% in 2024.
- Over 5 years, Shares Issued stood at $349374.0 in 2022, then changed by 0.0% to $349374.0 in 2023, then jumped by 82.27% to $636802.0 in 2024, then jumped by 55.89% to $992701.0 in 2025, then advanced by 29.53% to $1.3 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $1.3 million, $992701.0, and $995374.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34 Mn |
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 992,701.00 |
| Dec 31, 2025 | 992,701.00 |
| Sep 30, 2025 | 995,374.00 |
| Sep 30, 2025 | 995,374.00 |
| Jun 30, 2025 | 995,374.00 |
| Jun 30, 2025 | 995,374.00 |
| Mar 31, 2025 | 383,895.00 |
| Mar 31, 2025 | 383,895.00 |
| Dec 31, 2024 | 636,802.00 |
| Dec 31, 2024 | 636,802.00 |
| Sep 30, 2024 | 270,707.00 |
| Sep 30, 2024 | 270,707.00 |
| Jun 30, 2024 | 533,304.00 |
| Jun 30, 2024 | 533,304.00 |
| Mar 31, 2024 | 192,004.00 |
| Mar 31, 2024 | 192,004.00 |